Selective regulation of autoreactive B cells by FcγRIIB

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 149-157

  Venkatesh, Jeganathan ^a   Kawabata, Daisuke ^a   Kim, Sunjung ^a   Xu, Xiaonan ^a   Chinnasamy, Prameladevi ^a   Paul, Elahna ^b   Diamond, Betty ^a   Grimaldi, Christine M ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antibodies; Autoimmunity; B cells; Fc receptor; Lupus

Indexed keywords

B CELL ACTIVATING FACTOR; B LYMPHOCYTE RECEPTOR; DNA ANTIBODY; FC RECEPTOR IIB; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; GENE INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; INTERFERONS; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, IGG;

EID: 67349140375     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.009     Document Type: Article

References (65)

1. Takai T. Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 25 (2005) 1-18
2. Tarasenko T., Dean J.A., and Bolland S. FcgammaRIIB as a modulator of autoimmune disease susceptibility. Autoimmunity 40 (2007) 409-417
3. Pearse R.N., Kawabe T., Bolland S., Guinamard R., Kurosaki T., and Ravetch J.V. SHIP recruitment attenuates Fc gamma RIIB-induced B cell apoptosis. Immunity 10 (1999) 753-760
4. Phillips N.E., and Parker D.C. Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies. J Immunol 130 (1983) 602-606
5. Bolland S., Pearse R.N., Kurosaki T., and Ravetch J.V. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8 (1998) 509-516
6. Aman M.J., Tosello-Trampont A.C., and Ravichandran K. Fc gamma RIIB1/SHIP-mediated inhibitory signaling in B cells involves lipid rafts. J Biol Chem 276 (2001) 46371-46378
7. Xiang Z., Cutler A.J., Brownlie R.J., Fairfax K., Lawlor K.E., Severinson E., et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8 (2007) 419-429
8. Mackay M., Stanevsky A., Wang T., Aranow C., Li M., Koenig S., et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 203 (2006) 2157-2164
9. Su K., Yang H., Li X., Li X., Gibson A.W., Cafardi J.M., et al. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol 178 (2007) 3272-3280
10. Isaak A., Gergely Jr. P., Szekeres Z., Prechl J., Poor G., Erdei A., et al. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients. Int Immunol 20 (2008) 185-192
11. Blank M.C., Stefanescu R.N., Masuda E., Marti F., King P.D., Redecha P.B., et al. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 117 (2005) 220-227
12. Kyogoku C., Dijstelbloem H.M., Tsuchiya N., Hatta Y., Kato H., Yamaguchi A., et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46 (2002) 1242-1254
13. Floto R.A., Clatworthy M.R., Heilbronn K.R., Rosner D.R., MacAry P.A., Rankin A., et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 11 (2005) 1056-1058
14. Kono H., Kyogoku C., Suzuki T., Tsuchiya N., Honda H., Yamamoto K., et al. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 14 (2005) 2881-2892
15. Jiang Y., Hirose S., Abe M., Sanokawa-Akakura R., Ohtsuji M., Mi X., et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 51 (2000) 429-435
16. Pritchard N.R., Cutler A.J., Uribe S., Chadban S.J., Morley B.J., and Smith K.G. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10 (2000) 227-230
17. Rahman Z.S., and Manser T. Failed up-regulation of the inhibitory IgG Fc receptor Fc gamma RIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the Fc gamma RIIB gene. J Immunol 175 (2005) 1440-1449
18. Rahman Z.S., Alabyev B., and Manser T. FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity. J Immunol 178 (2007) 897-907
19. Takai T., Ono M., Hikida M., Ohmori H., and Ravetch J.V. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379 (1996) 346-349
20. Bolland S., and Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13 (2000) 277-285
21. McGaha T.L., Sorrentino B., and Ravetch J.V. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307 (2005) 590-593
22. Offen D., Spatz L., Escowitz H., Factor S., and Diamond B. Induction of tolerance to an IgG autoantibody. Proc Natl Acad Sci U S A 89 (1992) 8332-8336
23. Shefner R., Kleiner G., Turken A., Papazian L., and Diamond B. A novel class of anti-DNA antibodies identified in BALB/c mice. J Exp Med 173 (1991) 287-296
24. Spatz L., Saenko V., Iliev A., Jones L., Geskin L., and Diamond B. Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determination. J Exp Med 185 (1997) 1317-1326
25. Grimaldi C.M., Jeganathan V., and Diamond B. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J Immunol 176 (2006) 2703-2710
26. Venkatesh J., Peeva E., Xu X., and Diamond B. Cutting edge: hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J Immunol 176 (2006) 3311-3314
27. Bynoe M.S., Grimaldi C.M., and Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci U S A 97 (2000) 2703-2708
28. Bynoe M.S., Spatz L., and Diamond B. Characterization of anti-DNA B cells that escape negative selection. Eur J Immunol 29 (1999) 1304-1313
29. Iliev A., Spatz L., Ray S., and Diamond B. Lack of allelic exclusion permits autoreactive B cells to escape deletion. J Immunol 153 (1994) 3551-3556
30. Nieto A., Gaya A., Jansa M., Moreno C., and Vives J. Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol Immunol 21 (1984) 537-543
31. Yamagami T., ten Boekel E., Schaniel C., Andersson J., Rolink A., and Melchers F. Four of five RAG-expressing JCkappa-/- small pre-BII cells have no L chain gene rearrangements: detection by high-efficiency single cell PCR. Immunity 11 (1999) 309-316
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29 (2001) e45
33. Batten M., Fletcher C., Ng L.G., Groom J., Wheway J., Laabi Y., et al. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 172 (2004) 812-822
34. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 (1992) 1693-1702
35. Bengtsson A.A., Sturfelt G., Gullstrand B., and Truedsson L. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?. Clin Exp Immunol 135 (2004) 535-543
36. Peeva E., Michael D., Cleary J., Rice J., Chen X., and Diamond B. Prolactin modulates the naive B cell repertoire. J Clin Invest 111 (2003) 275-283
37. Borrero M., and Clarke S.H. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J Immunol 168 (2002) 13-21
38. Huang H., Kearney J.F., Grusby M.J., Benoist C., and Mathis D. Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen. Proc Natl Acad Sci U S A 103 (2006) 3734-3739
39. Fukuyama H., Nimmerjahn F., and Ravetch J.V. The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 6 (2005) 99-106
40. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003) 2610-2615
41. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197 (2003) 711-723
42. Kirou K.A., Lee C., George S., Louca K., Papagiannis I.G., Peterson M.G., et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum 50 (2004) 3958-3967
43. Feng X., Wu H., Grossman J.M., Hanvivadhanakul P., Fitzgerald J.D., Park G.S., et al. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 54 (2006) 2951-2962
44. Jorgensen T.N., Gubbels M.R., and Kotzin B.L. Links between type I interferons and the genetic basis of disease in mouse lupus. Autoimmunity 36 (2003) 491-502
45. Xin H., D'Souza S., Jorgensen T.N., Vaughan A.T., Lengyel P., Kotzin B.L., et al. Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol 176 (2006) 5863-5870
46. Lovgren T., Eloranta M.L., Bave U., Alm G.V., and Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 50 (2004) 1861-1872
47. Vallin H., Perers A., Alm G.V., and Ronnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol 163 (1999) 6306-6313
48. Rozzo S.J., Allard J.D., Choubey D., Vyse T.J., Izui S., Peltz G., et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15 (2001) 435-443
49. Boule M.W., Broughton C., Mackay F., Akira S., Marshak-Rothstein A., and Rifkin I.R. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199 (2004) 1631-1640
50. Lesley R., Xu Y., Kalled S.L., Hess D.M., Schwab S.R., Shu H.B., et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20 (2004) 441-453
51. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20 (2004) 785-798
52. Kalled S.L. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 204 (2005) 43-54
53. Mathsson L., Ahlin E., Sjowall C., Skogh T., and Ronnelid J. Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjogren's syndrome A antibodies. Clin Exp Immunol 147 (2007) 513-520
54. Ronnelid J., Tejde A., Mathsson L., Nilsson-Ekdahl K., and Nilsson B. Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis 62 (2003) 37-42
55. Desai D.D., Harbers S.O., Flores M., Colonna L., Downie M.P., Bergtold A., et al. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol 178 (2007) 6217-6226
56. Martinsson K., Carlsson L., Kleinau S., and Hultman P. The effect of activating and inhibiting Fc-receptors on murine mercury-induced autoimmunity. J Autoimmun 31 (2008) 22-29
57. Li H., Jiang Y., Prak E.L., Radic M., and Weigert M. Editors and editing of anti-DNA receptors. Immunity 15 (2001) 947-957
58. Li X., Su K., Ji C., Szalai A.J., Wu J., Zhang Y., et al. Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion. J Immunol 181 (2008) 1012-1018
59. Chun H.Y., Chung J.W., Kim H.A., Yun J.M., Jeon J.Y., Ye Y.M., et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27 (2007) 461-466
60. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181 (1995) 839-844
61. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
62. Llorente L., Richaud-Patin Y., Garcia-Padilla C., Claret E., Jakez-Ocampo J., Cardiel M.H., et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43 (2000) 1790-1800
63. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., and Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179 (1994) 305-310
64. Ji J.D., Tassiulas I., Park-Min K.H., Aydin A., Mecklenbrauker I., Tarakhovsky A., et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med 197 (2003) 1573-1583
65. Williams L., Bradley L., Smith A., and Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172 (2004) 567-576